DNTH (Dianthus Therapeutics, Inc.) Wutah pendapatan triwulanan

Simbol resmi perusahaan Dianthus Corp (DNTH)

Dianthus Therapeutics (DNTH) is fighting for patent leadership in the rare autoimmune pathology segment. The company is implementing eco-friendly antibody synthesis methods and strict ethical standards. The quarterly revenue growth trend confirms the development dynamics, recording the metric at 206.60. However, geopolitical tensions and reagent logistics disruptions are slowing the pace of international clinical trials.

DNTH (Dianthus Pharma) riwayat Wutah pendapatan triwulanan saka 21.02.2024 nganti 20.11.2026

Dianthus Therapeutics, Inc. (DNTH) - rincian metrik lan laporan keuangan

- data saldo dhuwit lan arus kas:
Analisis umum perusahaan:Dianthus Corp - DNTH
Barang unggulan dianthustx.com

This metric reflects the percentage change in revenue over the last three months relative to the previous quarter, capturing current sales momentum and the issuer's fundamental strength without time lags. For complement system inhibitor developer Dianthus Therapeutics (DNTH), the quarterly revenue growth rate serves as an indicator of the commercialization of the DNTH103 therapy, allowing investors to promptly identify capital drawdown risks should the pace of expansion in the immunology market slow.

Pesaing Dianthus Therapeutics (DNTH)

argenx BVBA - Wutah pendapatan triwulanan|BNTX: Wutah pendapatan kuartal marang kuartal|ABVX: Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ADMA|Wutah pendapatan kuartal marang kuartal protagonist-inc.com|Wutah dodolan triwulanan Immunovant, Inc. (IMVT)|Wutah pendapatan triwulanan KNSA|GRFS: Dinamika pendapatan kuartal marang kuartal|Adaptive Biotechnologies - Wutah dodolan triwulanan|CLDX: Wutah dodolan kuartal marang kuartal|Aurinia Corp - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal BioCryst Corp|VERA: Wutah pendapatan triwulanan|Pharvaris N.V. - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal AbCellera Biologics|Tourmaline Bio Inc (TRML) - Tingkat wutah dodolan sajrone kuartal|Wutah dodolan triwulanan PGEN (Intrexon)|PHAR (Pharming) - Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan NKTR (Nektar Therapeutics Inc)|Tingkat wutah dodolan sajrone kuartal upstreambio.com (UPB)|Zenas Biopharma - Wutah pendapatan triwulanan|IMNM (Immunome) - Wutah dodolan kuartal marang kuartal|gossamerbio.com (GOSS) - Wutah pendapatan kuartal marang kuartal|KalVista Corp (KALV) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal septerna.com|Wutah pendapatan triwulanan Pieris Pharmaceuticals|Wutah pendapatan kuartal marang kuartal Savara (SVRA)|RIGL - Tingkat wutah pendapatan sajrone kuartal|AnaptysBio Inc. - Wutah dodolan triwulanan|Wutah pendapatan triwulanan Astria Therapeutics ATXS|ENGN: Wutah dodolan triwulanan|RAPT Therapeutics Inc. (RAPT) - Wutah dodolan triwulanan|JBIO (Aerovate Therapeutics) - Wutah dodolan triwulanan|ACRS: Owah-owahan dodolan kuartal marang kuartal|KYTX (Kyverna Therapeutics, Inc) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal TLSA (Tiziana Life Sciences PLC)|Wutah pendapatan triwulanan CABA|Wutah pendapatan kuartal marang kuartal VTYX (Ventyx Biosciences, Inc.)|Wutah pendapatan kuartal marang kuartal Theratechnologies Inc THTX|Tingkat wutah dodolan sajrone kuartal Avalo Therapeutics, Inc. (AVTX)|ELDN - Wutah pendapatan kuartal marang kuartal|AGEN - Wutah pendapatan triwulanan|climbbio.com (CLYM) - Wutah pendapatan kuartal marang kuartal|Zura Bio - Tambahing pendapatan triwulanan|ATYR (atyrpharma.com) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ADAG (Adagene)|Wutah pendapatan triwulanan IMA|STTK (Shattuck Labs) - Tambahing pendapatan triwulanan|Equillium Inc - Wutah dodolan triwulanan|Tambahing pendapatan triwulanan CNTB|IMUX - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ATRA|IFRX (InflaRx) - Wutah dodolan triwulanan|X4 Pharma (XFOR) - Wutah pendapatan triwulanan|ACET (Adicet) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan celularity.com (CELU)|Wutah pendapatan kuartal marang kuartal INmune Bio Inc (INMB)|Tingkat wutah dodolan sajrone kuartal Barinthus Biotherapeutics PLC|Wutah pendapatan kuartal marang kuartal Kezar Life Sciences Inc KZR|Tambahing pendapatan triwulanan SABS|AKTX - Wutah pendapatan kuartal marang kuartal|Tambahing pendapatan triwulanan ENLV (enlivex.com)|QTTB: Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal GOVX|Wutah dodolan triwulanan EDSA|Wutah dodolan kuartal marang kuartal IBIO (iBio Corp)|Wutah pendapatan kuartal marang kuartal Carisma Therapeutics Inc (CARM)|Tingkat wutah dodolan sajrone kuartal xtlbio.com|Bolt Biotherapeutics Inc. - Wutah dodolan triwulanan|HCW Biologics Inc (HCWB) - Tingkat wutah pendapatan sajrone kuartal|Aptevo - Wutah pendapatan triwulanan|AIM ImmunoTech (AIM) - Wutah dodolan triwulanan|Aditxt Corp (ADTX) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal GRI|Wutah dodolan triwulanan XRTX|Tingkat wutah pendapatan sajrone kuartal Vyome Holdings Inc. HIND|Wutah pendapatan triwulanan REVB|Tingkat wutah dodolan sajrone kuartal Indaptus Corp|BiondVax Pharmaceuticals - Wutah dodolan triwulanan|CalciMedica Corp (CALI) - Tingkat wutah pendapatan sajrone kuartal|Affimed - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal allakos.com ALLK|HOOKIPA Pharma (HOOK) - Wutah pendapatan kuartal marang kuartal|IGMS (IGM Biosciences Inc.) - Wutah pendapatan kuartal marang kuartal|ITOS (iTeos Therapeutics) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal OCEA (Ocean Biomedical)|Wutah pendapatan kuartal marang kuartal TC Biopharm (TCBP)|THRD (Third Harmonic Bio Inc.) - Tambahing pendapatan triwulanan